Andrew Michael, MD
Ophthalmology · Henrico, VANPI 1902892201
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (42.3%), education and gifts — rather than concentrated in one kind of arrangement. 3 manufacturers reported payments, led by Carl Zeiss Meditec USA, Inc. at 42.3% of the total. That places this record below the midpoint for ophthalmology clinicians in VA, where the typical reported total is $1,018.
Across 4 payments — averaging $29.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec USA, Inc.$50
- AbbVie$49
- Carl Zeiss Meditec AG$19
Across 6 payments — averaging $996.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$6K
What the payments were for
- Food & beverage$5042%
- Education$4941%
- Gifts$1916%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec USA, Inc. | 2 | $50 |
| AbbVie | 1 | $49 |
| Carl Zeiss Meditec AG | 1 | $19 |
How this compares
$119 in reported general payments places this provider in the 15th percentile of 509 ophthalmology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 1,279 | $56,356 |
| LumiganBimatoprost | 85 | $34,821 |
| RhopressaNetarsudil Mesylate | 56 | $25,772 |
| Ketorolac Tromethamine | 1,410 | $20,184 |
| CombiganBrimonidine Tartrate/Timolol | 47 | $17,670 |
| Ofloxacin | 1,297 | $13,224 |
| Latanoprost | 1,289 | $9,954 |
| Timolol Maleate | 861 | $7,086 |
| Brimonidine Tartrate | 440 | $5,853 |
| Travoprost | 23 | $5,568 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 211 | $4,113 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 28 | $3,815 |
| Alphagan PBrimonidine Tartrate | 13 | $3,773 |
| Dorzolamide Hcl | 120 | $2,410 |
| Pilocarpine Hcl | 31 | $1,804 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Combigan, Alphagan P | $49 | $56,265145 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 509 ophthalmology providers in Virginia.
Other ophthalmology in Henrico
- Ethnie JonesRichmond$2M
- Elizabeth Yeu-LinNorfolk$1.7M
- John SheppardNorfolk$1.1M
- Constance OkekeNorfolk$800K
- Marc OdrichCharlottesville$497K
- Jayakrishna AmbatiCharlottesville$116K
- Thomas JolyNorfolk$95K
- Stephen ScoperNorfolk$88K
- Leonard RappaportPortsmouth$85K
- Soheila RostamiReston$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.